These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3523023

  • 21. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
    Creutzig U, Ritter J, Heyen P, Berthold F, Henze G, Kabisch H, Lampert F, Niethammer D, Riehm H, Schellong G.
    Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study].
    Gobrecht O, Göbel U, Graubner U, Gutjahr P, Schöck V, Spaar HJ, Janka-Schaub GE.
    Klin Padiatr; 1992 Jan; 204(4):230-5. PubMed ID: 1518258
    [Abstract] [Full Text] [Related]

  • 27. [Progress in the treatment of juvenile leukemias].
    Gadner H, Krepler P, Kundi M, Mutz I, Pichler E, Schmidmeier W, Tulzer W, Urban C.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):313-8. PubMed ID: 6958132
    [Abstract] [Full Text] [Related]

  • 28. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G, Göbel U, Jorch N, Spaar HJ, Janka-Schaub GE.
    Klin Padiatr; 2007 Jul 31; 219(3):134-8. PubMed ID: 17525906
    [Abstract] [Full Text] [Related]

  • 29. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
    Castel V, Verdeguer A, Ferris J, Esquembre C.
    An Esp Pediatr; 1987 Nov 31; 27(5):331-4. PubMed ID: 3481522
    [Abstract] [Full Text] [Related]

  • 30. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 31; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 31. [The COALL-85 cooperative study for risk patients with acute lymphatic leukemia: initial results].
    Janka-Schaub GE, Winkler K, Göbel U, Graubner U, Schwenger M, Haas RJ, Jürgens H, Spaar J.
    Klin Padiatr; 1988 Jul 31; 200(3):171-6. PubMed ID: 3062253
    [Abstract] [Full Text] [Related]

  • 32. Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Miller DR, Leikin SL, Albo VC, Sather H, Hammond GD.
    J Clin Oncol; 1989 Mar 31; 7(3):316-25. PubMed ID: 2645385
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, Rammeloo JA, de Koning J, van Zanen GE.
    Tijdschr Kindergeneeskd; 1988 Apr 31; 56(2):61-6. PubMed ID: 3287685
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, Law T, Cross S, Mueller H, de Haas V, Haber M, Révész T, Alvaro F, Suppiah R, Norris MD, Pieters R.
    Leukemia; 2013 Jul 31; 27(7):1497-503. PubMed ID: 23407458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.